<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Repetitive measurement with neuroimaging techniques could be useful instruments permitting to differentiate between <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) </plain></SENT>
<SENT sid="1" pm="."><plain>The major genetic risk factor for the development of <z:hpo ids='HP_0003584'>late-onset</z:hpo> AD is the allele epsilon4 of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (ApoE) </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) seems to be correlated with the degree of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to investigate the association between serum NO and <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels, global brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> and brain vascular lesion in AD and VD patients </plain></SENT>
<SENT sid="4" pm="."><plain>We report that high plasma levels of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> resulted associated with AD and VD, suggesting that in AD elevated plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> might be a consequence of concomitant vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Otherwise, plasma NO levels were not significantly different in any of the groups </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, neuroimaging measures of vascular lesion level could be of usefulness to differentiate between AD and VD </plain></SENT>
</text></document>